Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients

Silvia Liu, Michael A. Nalesnik, Aatur Singhi, Michelle A. Wood‐Trageser, Parmjeet Randhawa, Bao‐Guo Ren, Abhinav Humar, Peng Liu, Yan‐Ping Yu, George C. Tseng, George Michalopoulos, Jian‐Hua Luo – 31 October 2021 – Hepatocellular carcinoma (HCC) is one of the most lethal human cancers. Liver transplantation has been an effective approach to treat liver cancer. However, significant numbers of patients with HCC experience cancer recurrence, and the selection of suitable candidates for liver transplant remains a challenge.

Palliative Care Always: Hepatology—Virtual Primary Palliative Care Training for Hepatologists

Jan C. DeNofrio, Manisha Verma, Andrzej S. Kosinski, Victor Navarro, Tamar H. Taddei, Michael L. Volk, Marie Bakitas, Kavitha Ramchandran – 30 October 2021 – Palliative care (PC) benefits patients with serious illness including end‐stage liver disease (ESLD). As part of a cluster randomized trial, hepatologists were trained to deliver primary palliative care to patients with ESLD using an online course, Palliative Care Always: Hepatology (PCA:Hep). Here we present a multimethod formative evaluation (feasibility, knowledge acquisition, self‐efficacy, and practice patterns) of PCA:Hep.

An RNA Interference/Adeno‐Associated Virus Vector–Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus

Cindy Zhang, Andrew Freistaedter, Carolin Schmelas, Manuel Gunkel, Viet Loan Dao Thi, Dirk Grimm – 30 October 2021 – Hepatitis E virus (HEV) is a major public health problem with limited therapeutic options. Here, we engineered adeno‐associated viral vectors of serotype 6 (AAV6) to express short hairpin RNAs (shRNAs) against HEV transcripts with the prospect of down‐regulating HEV replication in vivo. We designed 20 different shRNAs, targeting the genome of the HEV genotype 3 (GT3) Kernow‐C1 p6 strain, for delivery upon AAV6 transduction.

Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies

Philipp Königshofer, Benedikt Silvester Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, Oleksandr Petrenko, Katharina Wöran, Merima Herac, Judith Stift, Katharina Lampichler, Gerald Timelthaler, David Bauer, Lukas Hartl, Bernhard Robl, Maria Sibila, Bruno K. Podesser, Georg Oberhuber, Philipp Schwabl, Mattias Mandorfer, Michael Trauner, Thomas Reiberger – 29 October 2021

Mucosal‐associated invariant T‐cell tumor infiltration predicts long‐term survival in cholangiocarcinoma

Christine L. Zimmer, Iva Filipovic, Martin Cornillet, Colm J. O’Rourke, Lena Berglin, Hannes Jansson, Dan Sun, Otto Strauss, Laura Hertwig, Helene Johansson, Erik Seth, Ernesto Sparrelid, Joana Dias, Hans Glaumann, Espen Melum, Ewa C. Ellis, Johan K. Sandberg, Jesper B. Andersen, Annika Bergquist, Niklas K. Björkström – 29 October 2021

Subscribe to